IRCT20230831059311N1招募中3 期
Investigating the effect of Sarcomeal oral supplementation and vitamin D3 on muscle parameters and metabolic factors in patients with diabetic sarcopenia: a randomized open-label clinical trial with parallel groups
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50 years 至 75 years（—）
- 性别
- All
入选标准
- •At least a history of 6 months of type 2 diabetes confirmed by a specialist doctor
- •Diagnosis of sarcopenia according to the criteria mentioned in the study method
- •Signing a written consent to participate in the study
- •Not using other supplements
- •Absence of severe hepatic or renal disorder
- •Absence of cancer
排除标准
- •Existence of musculoskeletal disorders (back pain, knee pain, etc.) that lead to impaired walking
- •The existence of comorbid orthopedic and neurological problems such as stroke, cerebral palsy, poliomyelitis, rheumatoid arthritis, and prosthesis
- •The patient's unwillingness to cooperate
- •Occurrence of any unforeseen problems in patients
- •Not using more than 10% of supplements given in each follow-up
研究者
相似试验
已完成
不适用
A study for evaluating the effect of oral supplementation using gamma-aminobutyric acid (GABA) and whey protein on muscle hypertrophy in meHealthy menJPRN-UMIN000025842Pharma Foods International Co., Ltd.26
已完成
不适用
The clinical study for the effect of oral supplementary drugs containing lutein on macular pigment densityThe patients with early age-related macular degeneration and healthy volunteer participantsJPRN-UMIN000011512The department of Ophthalmology, School of medicine, The university of tokyo40
已完成
不适用
Analysis of the effect of oral nutritional supplement or branched chain amino acid (BCAA) on liver cirrhotic patients with less than 3.5 g/dl of serum albumin level.JPRN-UMIN000011183Kanazawa Medical University40
招募中
2 期
Role of an Ayurvedic Formulation in Management of Vitiligo in ChildreCTRI/2020/03/024214ayan Kumar S
尚未招募
3 期
The effect of jujube and saffron supplement on Covid-19Covid-19.Covid-19U07.1IRCT20160305026917N2Birjand University of Medical Sciences60